Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Connexin 43 deficiency accelerates skin wound healing and extracellular matrix remodeling in mice

Full text
Author(s):
Cogliati, Bruno [1] ; Vinken, Mathieu [2] ; Silva, Tereza C. [1] ; Araujo, Cintia M. M. [1] ; Aloia, Thiago P. A. [1] ; Chaible, Lucas M. [1] ; Mori, Claudia M. C. [1] ; Dagli, Maria L. Z. [1]
Total Authors: 8
Affiliation:
[1] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, BR-05508270 Sao Paulo - Brazil
[2] Vrije Univ Brussel, Dept Vitro Toxicol & Dermato Cosmetol, Brussels - Belgium
Total Affiliations: 2
Document type: Journal article
Source: JOURNAL OF DERMATOLOGICAL SCIENCE; v. 79, n. 1, p. 50-56, JUL 2015.
Web of Science Citations: 19
Abstract

Background: Cellular channels composed of connexin 43 are known to act as key players in the life cycle of the skin and consequently to underlie skin repair. Objective: This study was specifically set up to investigate the suite of molecular mechanisms driven by connexin 43-based channels on wound healing. Methods: To this end, a battery of parameters, including re-epithelialization, neovascularization, collagen deposition and extracellular matrix remodeling, was monitored over time during experimentally induced skin repair in heterozygous connexin 43 knockout mice. Results: It was found that connexin 43 deficiency accelerates re-epithelialization and wound closure, increases proliferation and activation of dermal fibroblasts, and enhances the expression of extracellular matrix remodeling mediators. Conclusion: These data substantiate the notion that connexin 43 may represent an interesting therapeutic target in dermal wound healing. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved. (AU)

FAPESP's process: 13/50420-6 - Connexin and pannexin channels as drug targets and biomarkers in acute and chronic liver disease
Grantee:Mathieu Frederick Alexander Vinken
Support Opportunities: Research Projects - SPEC Program